Skip to content

The difference of GOLM1 expression level in endometrial lesions

The difference of GOLM1 expression level in endometrial lesions

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116681
Enrollment
Unknown
Registered
2026-01-13
Start date
2025-03-18
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial hyperplasia was not accompanied by atypical hyperplasia. Endometrial atypical hyperplasia

Interventions

Observation group of endometrial lesions:None

Sponsors

The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.They are between 25 and 80 years old. 2.Endometrial hyperplasia group: All patients showed endometrial hyperplasia (including endometrial hyperplasia without atypical hyperplasia; Endometrial atypical hyperplasia). 3.Endometrial cancer group: All patients were found to have endometrial cancer. 4.Before enrollment, all patients had not received any other adjuvant therapy, including radiotherapy, immunotherapy, and chemotherapy. 5.All patients gave informed consent.

Exclusion criteria

Exclusion criteria: 1.A history of other primary malignancies. 2.Hysteroscopy or other intervention prior to surgery. 3.Serious underlying disease.

Design outcomes

Primary

MeasureTime frame
GOLM1;

Countries

China

Contacts

Public ContactHou Yu

The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology

231553192@qq.com+86 472 217 8197

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026